Nov 19, 2017

Site goes live

Website goes live in November! Location: Time: November 1, 2017 For more information, please contact us.

Nov 3, 2017

scPharmaceuticals Announces FDA Acceptance of NDA for Furoscix (subcutaneous furosemide)

FOR IMMEDIATE RELEASE: BURLINGTON, MA., — scPharmaceuticals, Inc., a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way therapy is delivered, advance patient care and reduce healthcare costs, today announced that the 505(b)(2) New Drug Application (NDA) for Furoscix has been accepted for filing by the U.S. Food and Drug Administration (FDA).